HOME >> MEDICINE >> NEWS
Progesterone therapy could prevent thousands of preterm births

WHITE PLAINS, N.Y., JAN. 31, 2005 -- Nearly 10,000 preterm births could have been prevented in 2002 if all pregnant women at high risk for a premature baby and eligible for weekly injections of a derivative of the hormone progesterone had received them, according to a new study published in the February issue of Obstetrics & Gynecology.

The result would have been a reduction in the overall rate of preterm birth (before 37 completed weeks gestation) in the United States of about 2 percent -- from the 2002 rate of 12.1 percent to 11.8 percent -- say Joann R. Petrini, Ph.D., M.P.H., and colleagues from the March of Dimes, the Centers for Disease Control and Prevention, the National Institute of Child Health and Human Development (NICHD), Albert Einstein College of Medicine, Maimonides Medical Center in New York, and the New Jersey and Missouri State Departments of Health who participated in the analyses.

The hormone derivative is known as 17P, short for 17 alpha-hydroxyprogesterone caproate.

"Two percent would be a modest reduction in the preterm birth rate, but preventing 10,000 premature births would be very significant," said Dr. Petrini. "Prematurity is a serious problem that affects 1 in 8 babies in the U.S., and 17P offers promise in an area where there have been few successes. In addition, we need more research into the underlying causes of prematurity to help women with other risk factors."

Assumptions used to estimate the impact of 17P on recurrent preterm birth were based on criteria from the promising findings of the clinical trial reported by Paul J. Meis, M.D., et al. for the NICHD Maternal-Fetal Medicine Units (MFMU) Network in The New England Journal of Medicine on June 12, 2003. These study results led to the 2003 Committee Opinion issued by the American College of Obstetrician's and Gynecologists, published in the October 2003 issue of Obstetrics & Gynecology.

In the NICHD MFMU study
'"/>

Contact: Michele Kling
mkling@marchofdimes.com
914-997-4613
March of Dimes Birth Defects Foundation
31-Jan-2005


Page: 1 2

Related medicine news :

1. Study shows patch therapy may be as effective as oral medications
2. Novel therapy tested in mice could chase away cat allergies
3. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack
4. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
5. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
6. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
7. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
8. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
9. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
10. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder
11. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Progesterone therapy could prevent thousands preterm births

(Date:8/1/2014)... 01, 2014 As AndroGel lawsuits and ... Ronald E. Johnson, Jr. has been appointed as co-lead ... other testosterone medications. Since the Fall of 2013, Ron ... worked diligently to investigate and prosecute the claims of ... blood clots as a result of taking testosterone. As ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Growing ... coverage and healthcare reforms are boosting healthcare market ... medicines through discounts and increasing generic consumption is ... approximately 76.7 million in 2013, having grown at ... from 2008. The implementation of the Health Transformation ...
(Date:8/1/2014)... The "Antimicrobial Coatings Market by Type (Silver, Copper, ... and Zinc Omadine), Application (Indoor air/HVAC, Medical, Mold ... and others), & Geography (North America, Europe, Asia-Pacific, ... 2018" analyzes the Antimicrobial Coatings Market with respect ... diverse geographical regions. , Browse 49 market data ...
(Date:8/1/2014)... According to new market research report "Automotive ... Europe, & ROW), by Vehicle Type (Passenger Cars, ... Diesel), by After-Treatment Device (DPF, DOC, SCR, TWC, ... 2019", defines and segments the global automotive exhaust ... in all the regions, and estimates their exhaust ...
(Date:8/1/2014)... August 1, 2014 The Cardiovascular Research ... first report investigations that will be presented at ... symposium. TCT, the world,s premier educational meeting specializing ... 13 17, 2014 at the Walter E. ... research data presented at TCT often direct the ...
Breaking Medicine News(10 mins):Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4
(Date:8/1/2014)... -- In the latest call for gender equity in ... 60 doctors and leading medical experts from across the ... and Drug Administration,s (FDA) decision to approve 26 drugs ... dysfunction compared with ZERO for women,s most common complaint, ... by approving the first-ever drug to treat Hypoactive Sexual ...
(Date:8/1/2014)... , August 1, 2014 ... Market by Type (Traditional Wound Closure, Anti infective), Basic ... (Artificial Skin & Skin Substitutes), Pressure Relief Devices, ... MarketsandMarkets, the global Wound Care Market is expected to ... in 2014, growing at a CAGR of 3.2% ...
(Date:8/1/2014)... PLYMOUTH MEETING, Pa. , Aug. 1, 2014 /PRNewswire/ ... that it will host a conference call to report ... 11, 2014 at 9:00 AM ET. CEO Dr. ... will discuss second quarter earnings, provide a corporate ... The update will include clinical development plans for VGX-3100, ...
Breaking Medicine Technology:60+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3
Cached News: